Sun Pharma Recalls More Than 30,000 Bottles of Antidepressants

International Pharmaceutical Regulatory Monitor
A A
Sun Pharmaceuticals has initiated a recall of more than 30,000 bottles of bupropion hydrochloride extended-release tablets for the treatment of major depressive disorder and seasonal affective disorder.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor